BioCentury
ARTICLE | Company News

Corautus, Boston Scientific deal

August 4, 2003 7:00 AM UTC

The companies partnered to deliver CAQ's VEGF-2 gene using a BSX cardiac delivery catheter. The companies initially will focus on treating severe ischemic heart disease in patients not responding to c...